Sequential blood purification therapy for critical patients with hyperlipidemic severe acute pancreatitis

Table 4 Comparison of laboratory variables

Variable	Study group (n = 15)	Control group (n = 16)
WBC (109/L)	11.5 ± 2.3	13.1 ± 2.9
PLT (109/L)	196.5 ± 40.5	199.6 ± 58.7
ALB (g/L)	37.8 ± 4.6a	38.9 ± 5.7
ALT (U/L)	54.3 ± 20.4	59.7 ± 23.1
TBIL (mmol/L)	20.1 ± 3.9	25.3 ± 4.2
BUN (mmol/L)	7.8 ± 2.6	9.7 ± 2.8
Scr (mmol/L)	149.8 ± 30.2	139.3 ± 37.5
Ca2+ (mmol/L)	2.1 ± 0.5	2.0 ± 0.3
Serum amylase (U/L)	74.4 ± 28.3	82.1 ± 20.7
Urine amylase (U/L)	399.7 ± 59.7	387.1 ± 51.4
CRP (mg/L)	20.5 ± 6.4a	28.5 ± 7.1
PCT (ng/mL)	1.33 ± 0.42a	1.71 ± 0.61

^aP < 0.05 vs control group. ALB: Albumin; ALT: Alanine transaminase; BUN: Urea nitrogen; CRP: C-reactive protein; PCT: Procalcitonin; PLT: Platelet; Scr: Serum creatinine; TBIL: Total bilirubin; WBC: White blood cell.